Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Approaching the challenges of MKK3/p38delta MAPK targeting for therapeutic purpose in colorectal cancer.

Stramucci L, Bossi G.

J Exp Clin Cancer Res. 2019 Dec 27;38(1):504. doi: 10.1186/s13046-019-1513-4.

2.

MKK3 sustains cell proliferation and survival through p38DELTA MAPK activation in colorectal cancer.

Stramucci L, Pranteda A, Stravato A, Amoreo CA, Pennetti A, Diodoro MG, Bartolazzi A, Milella M, Bossi G.

Cell Death Dis. 2019 Nov 6;10(11):842. doi: 10.1038/s41419-019-2083-2.

3.

Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer.

Stramucci L, Pranteda A, Bossi G.

Cancers (Basel). 2018 May 3;10(5). pii: E131. doi: 10.3390/cancers10050131. Review.

4.

Author Correction: The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries.

Grasso S, Chapelle J, Salemme V, Aramu S, Russo I, Vitale N, di Cantogno LV, Dallaglio K, Castellano I, Amici A, Centonze G, Sharma N, Lunardi S, Cabodi S, Cavallo F, Lamolinara A, Stramucci L, Moiso E, Provero P, Albini A, Sapino A, Staaf J, Di Fiore PP, Bertalot G, Pece S, Tosoni D, Confalonieri S, Iezzi M, Di Stefano P, Turco E, Defilippi P.

Nat Commun. 2018 Mar 30;9:16203. doi: 10.1038/ncomms16203.

5.

The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries.

Grasso S, Chapelle J, Salemme V, Aramu S, Russo I, Vitale N, Verdun di Cantogno L, Dallaglio K, Castellano I, Amici A, Centonze G, Sharma N, Lunardi S, Cabodi S, Cavallo F, Lamolinara A, Stramucci L, Moiso E, Provero P, Albini A, Sapino A, Staaf J, Di Fiore PP, Bertalot G, Pece S, Tosoni D, Confalonieri S, Iezzi M, Di Stefano P, Turco E, Defilippi P.

Nat Commun. 2017 Mar 16;8:14797. doi: 10.1038/ncomms14797. Erratum in: Nat Commun. 2018 Mar 30;9:16203.

6.

Twisting IL-1 signaling to kill CML stem cells.

Stramucci L, Perrotti D.

Blood. 2016 Dec 8;128(23):2592-2593. No abstract available.

PMID:
27932325
7.

Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay.

Perrotti D, Silvestri G, Stramucci L, Yu J, Trotta R.

Curr Drug Targets. 2017;18(4):377-388. doi: 10.2174/1389450117666160615074120. Review.

8.

Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor.

Lamolinara A, Stramucci L, Hysi A, Iezzi M, Marchini C, Mariotti M, Amici A, Curcio C.

J Immunol Res. 2015;2015:159145. doi: 10.1155/2015/159145. Epub 2015 Jul 13.

9.

Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice.

Macagno M, Bandini S, Stramucci L, Quaglino E, Conti L, Balmas E, Smyth MJ, Lollini PL, Musiani P, Forni G, Iezzi M, Cavallo F.

J Immunol. 2014 Jun 1;192(11):5434-41. doi: 10.4049/jimmunol.1301248. Epub 2014 Apr 30.

10.

Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).

Gabrielli F, Salvi R, Garulli C, Kalogris C, Arima S, Tardella L, Monaci P, Pupa SM, Tagliabue E, Montani M, Quaglino E, Stramucci L, Curcio C, Marchini C, Amici A.

PLoS One. 2013;8(3):e58358. doi: 10.1371/journal.pone.0058358. Epub 2013 Mar 28.

11.

Human responses against HER-2-positive cancer cells in human immune system-engrafted mice.

De Giovanni C, Nicoletti G, Landuzzi L, Romani F, Croci S, Palladini A, Murgo A, Antognoli A, Ianzano ML, Stivani V, Grosso V, Iezzi M, Stramucci L, Barbieri E, Lemoli RM, Nanni P, Lollini PL.

Br J Cancer. 2012 Oct 9;107(8):1302-9. doi: 10.1038/bjc.2012.394. Epub 2012 Aug 28.

Supplemental Content

Loading ...
Support Center